Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
-102.84%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Processa Pharmaceuticals, Inc.
Market Cap
$4.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.32M
Operating Margin
-162.87%
TTM Avg
-242.97%
3Y Avg
-229.35%
5Y Avg
-164.06%
Market Cap
$4.40M
Operating Margin
-484.31%
TTM Avg
-1917.01%
3Y Avg
-2405.16%
5Y Avg
-1618.57%
Market Cap
$3.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-229.94%
5Y Avg
-288.65%
Market Cap
$3.90M
Operating Margin
-774.90%
TTM Avg
-1185.31%
3Y Avg
-1296.90%
5Y Avg
-883.94%
Market Cap
$4.53M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | $4.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | 0.00% | 0.00% | -243.17% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -162.87% | -242.97% | -229.35% | -164.06% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | -484.31% | -1917.01% | -2405.16% | -1618.57% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 0.00% | 0.00% | -229.94% | -288.65% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -774.90% | -1185.31% | -1296.90% | -883.94% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| CalciMedica, Inc. (CALC)vs › | $4.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $4.71M | 0.00% | 0.00% | -1246.08% | -2147.17% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | -1510.30% |
| 2015-12-31 | 749.78% |
| 2015-09-30 | -327.46% |
| 2015-06-30 | -9434.57% |
| 2015-03-31 | -1285.73% |
| 2014-12-31 | -10251.13% |
| 2014-09-30 | -1257.66% |
| 2014-06-30 | -654.28% |
| 2014-03-31 | -6312.25% |
| 2013-12-31 | -1130.78% |
| 2013-09-30 | -535.64% |
| 2013-06-30 | -712.59% |
| 2013-03-31 | -4172.48% |
| 2012-12-31 | -2464.29% |
| 2012-09-30 | -1158.02% |
| 2012-06-30 | -417.60% |
| 2012-03-31 | -3640.00% |
| 2011-12-31 | -5400.00% |
